Two Studies. Two Clinical Lessons.

Two Studies. Two Clinical Lessons.

When evidence is neutral—or a treatment is still experimental—clinical interpretation matters.

MATERNAL HEALTH / ALLERGY

CAN MATERNAL DIET PREVENT

INFANT FOOD ALLERGY?

7.8% vs 8.4%

THE STUDY. PrEggNut randomized 2,137 women with familial allergy risk to higher or standard egg/peanut intake during pregnancy and lactation.

KEY RESULT. Infant egg/peanut allergy at 1 year: 7.8% vs 8.4% (RR 0.93; 95% CI 0.69–1.26; P=0.65). No significant reduction.

MEDEASY TAKE High maternal intake did not lower infant allergy risk. This does not imply allergen avoidance.

OPHTHALMOLOGY / INNOVATION

OPTOGENETICS: A SIGNAL OF

RESTORED LIGHT SENSITIVITY

7 / 10

Increased light sensitivity

THE STUDY. PIONEER was an open-label phase 1 safety study (n=10) in advanced retinitis pigmentosa using an intravitreal ChrimsonR vector and light-stimulating goggles.

KEY RESULT. Seven showed increased light sensitivity; six met a meaningful threshold not prespecified in the protocol. This was not restoration of normal vision.

SAFETY. There were 34 ocular adverse events in nine participants, including one severe transient central retinal artery occlusion.

MEDEASY TAKE An encouraging biological signal; functional benefit and long-term safety remain uncertain.

DISCLOSURE: PIONEER was funded by GenSight Biologics. This article is independent editorial content.